Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
Some observational studies raised questions about the need for β-blockers in all patients after a first heart attack. Surprisingly, in some clinical settings, a limited mortality reduction was found in those who received β-blockade.Some studies suggest that patients without heart failure may not nee...
Main Author: | Roberto F.E. Pedretti |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2018-06-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/971 |
Similar Items
-
β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study
by: Tora Hagsund, et al.
Published: (2020-04-01) -
Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
by: Liyew Desta, et al.
Published: (2021-02-01) -
Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction—A Nationwide Cohort Study
by: Sheng-Fu Liu, et al.
Published: (2021-09-01) -
Beta adrenergic blockade in myocardial infarction
by: Yusuf, Salim
Published: (1980) -
Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
by: Mari Amino, et al.
Published: (2021-07-01)